This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: The automated Galaxy-SynBioCAD pipeline for synthetic biology design and engineering

Title The automated Galaxy-SynBioCAD pipeline for synthetic biology design and engineering
Abstract

Here we introduce the Galaxy-SynBioCAD portal, a toolshed for synthetic biology, metabolic engineering, and industrial biotechnology. The tools and workflows currently shared on the portal enables one to build libraries of strains producing desired chemical targets covering an end-to-end metabolic pathway design and engineering process from the selection of strains and targets, the design of DNA parts to be assembled, to the generation of scripts driving liquid handlers for plasmid assembly and strain transformations. Standard formats like SBML and SBOL are used throughout to enforce the compatibility of the tools. In a study carried out at four different sites, we illustrate the link between pathway design and engineering with the building of a library of E. coli lycopene-producing strains. We also benchmark our workflows on literature and expert validated pathways. Overall, we find an 83% success rate in retrieving the validated pathways among the top 10 pathways generated by the workflows.

Apa Reference Hérisson, J., Duigou, T., du Lac, M., Bazi-Kabbaj, K., Sabeti Azad, M., Buldum, G., Telle, O., El Moubayed, Y., Carbonell, P., Swainston, N., Zulkower, V., Kushwaha, M., Baldwin, G. S., & Faulon, J.-L. (2022). The automated Galaxy-SynBioCAD pipeline for synthetic biology design and engineering. Nature Communications, 13(1). 10.1038/s41467-022-32661-x
Doi 10.1038/s41467-022-32661-x
Publication Date 29 Aug 2022
Publication Type Software
Researcher Pablo Carbonell
Ontology Model organisms, Benchmarking, Workflow managers, Pathway analysis
Research Groups Dynamics Biodesign Lab
Tools Galaxy-SynBioCAD

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home